Xeltis secures €12.5M from EIC Fund, DaVita Venture Group, EQT Life Sciences, Kurma Partners, VI Partners, and Ysios Capital.

Biotech Health services Pharma

Investments

13 August 2023

Xeltis (company)

Biotech Health services Pharma

Total investments received (USD): 52.27m

Round value (USD): 13.81m

Round investors: EIC Fund EQT Partners Kurma Life Science Partners VI Partners AG Ysios Capital DaVita Venture Group

Company: Xeltis

Industry: Biotech Health services Pharma

Biotech Health services Manufacturing

Investments 03 November 2023

Health services Manufacturing Pharma

Investments 01 May 2023